Immunocore
IMCR
49 hedge funds and large institutions have $642M invested in Immunocore in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
4% more funds holding
Funds holding: 47 → 49 (+2)
2.46% more ownership
Funds ownership: 38.78% → 41.23% (+2.5%)
4% more capital invested
Capital invested by funds: $617M → $642M (+$25M)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.1M |
| 2 |
First Manhattan
New York
|
+$11.3M |
| 3 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
+$6.88M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$5.77M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$12M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.95M |
| 3 |
Millennium Management
New York
|
-$3.48M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.09M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.45M |
IMCR Hedge Fund Activity: Q4 2021 in Review
49 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q4 2021, worth a combined $642M — up 4.1% from $617M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMCR positions and 6 closed out — a net gain of 3 holders — while 13 added to existing stakes and 14 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $13.1M. The largest seller was BlackRock, cutting an estimated $12M.
- 49 institutional investors held Immunocore (IMCR) as of Q4 2021, up from 47 in Q3 2021.
- Funds reported $642M of Immunocore stock for Q4 2021, up 4.1% quarter-over-quarter.
- 9 funds opened new Immunocore positions in Q4 2021 and 6 closed out, a net change of +3 holders.
- The largest Immunocore buyer in Q4 2021 was Wellington Management Group, an estimated $13.1M added.
- The largest Immunocore seller in Q4 2021 was BlackRock, an estimated $12M sold.
Based on aggregated 13F filings for Q4 2021.